January 22nd, 2022
64x Bio's iterative solutions to vector manufacturing pain points
January 19th, 2022
Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech
January 19th, 2022
A George Church spinout fighting the viral vector bottleneck in cell and gene therapy lands $55M
January 19th, 2022
January 19th, 2022
64x Bio Raises $55M To Advance Gene Therapy Platform
January 19th, 2022
64x Bio Lands $55 Million for Gene-Therapy Tech
January 19th, 2022
November 20th, 2020
George Church backs a startup solution to the massive gene therapy manufacturing bottleneck
November 16th, 2020
64x Bio emerges from stealth to drive an evolution in cell and gene therapy manufacturing
December 27, 2019
December 8, 2019
A Harvard geneticist's goal: to protect humans from viruses, genetic diseases, and aging
December 3, 2019
The synthetic biology revolution is here
November 18, 2019
SynBioBeta: synthetic biology the next big thing after computers
November 7, 2019
Harvard scientist’s breakthrough could make humans resistant to all viruses
February 26, 2019
What’s in the water at the George Church lab?
August 24, 2018
The female-founded startups at Y Combinator Demo Day 2
August 22, 2018
At Y Combinator, startups manage molecules rather than code
August 22, 2018
The top 10 startups from Y Combinator's Demo Day S18 day 2
August 21, 2018
All 59 startups that launched today at Y Combinator's S18 Demo Day 2